trending Market Intelligence /marketintelligence/en/news-insights/trending/2u1vv1wheq7qkvwveniz2g2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Neuralstem CEO to resign

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Neuralstem CEO to resign

Richard Daly plans to resign as CEO, CFO, president and director of Neuralstem Inc. after a transitional period.

Daly's resignation from the board did not result from any disagreement on any matter relating to the company's operations, policies or practices, according to Neuralstem.

The company expects to start a search for Daly's replacement to assume his duties after the completion of the transitional period.

Germantown, Md.-based Neuralstem is a clinical-stage biopharmaceutical company that focuses on the research and development of nervous system therapies based on its proprietary human neuronal stem cells and small molecule compounds.